AR and prostate cancer: Furthermore, GATA2-mediated increased chromatin accessibility facilitated the binding of other TFs, including androgen receptor (AR) and SRY-Box Transcription Factor 9 (Sox9), to CREs in prostate cancer cell lines (54, 55, 56).